Vaxxas has received a manufacturing licence from Australia’s Therapeutic Goods Administration (TGA) for its high-density ...

The global protein chip market size is valued at USD 2.36 billion in 2025 and is predicted to hit around USD 4.98 billion by ...

The Global Gene Expression Market is estimated to be valued at USD 16.56 Bn in 2025 and is expected to reach USD 23.61 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.2% from 2025 to ...

Some of our most promising biotechs have taken part in a pre yuletide rush of clinical trial updates – and there is much to ...

With an estimated more than 10 million cases, India accounts for nearly 20% of the global epilepsy burden. The number of ...

With over a decade of experience architecting and operating large-scale cloud environments across AWS, Azure, and Google ...

Promising BioTech Vaxxas on Monday announced it will begin manufacturing its needle free vaccination patches in Brisbane for ...

Australian biotech innovator Vaxxas has secured a major milestone in its journey to revolutionise vaccine delivery. The ...

The global advanced dermatology drug delivery devices market size was US$ 3,569.9 million in 2021. The global advanced dermatology drug delivery devices market size is forecast to reach US$ 8,785.0 ...